In summary, combined both GLP-1 RA and basal insulin therapy showed a significant improvement of glycemic indices, cardiovascular benefits, and GV among patients with uncontrolled T2D on previous therapy with premixed insulin. Here, INS is linked to type 2 diabetes mellitus.